Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
317.09
+2.92 (0.93%)
At close: Nov 20, 2024, 4:00 PM
320.00
+2.91 (0.92%)
Pre-market: Nov 21, 2024, 4:14 AM EST
Madrigal Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 340.37 | 108.15 | 48.13 | 37.32 | 21.86 | 22.65 | |
Research & Development | 281.71 | 272.35 | 245.44 | 205.16 | 184.81 | 72.32 | |
Operating Expenses | 622.08 | 380.5 | 293.57 | 242.48 | 206.67 | 94.97 | |
Operating Income | -548.06 | -380.5 | -293.57 | -242.48 | -206.67 | -94.97 | |
Interest Expense | -15.14 | -12.71 | -3.96 | - | - | - | |
Interest & Investment Income | 44.53 | 19.58 | 2.19 | 0.36 | 4.33 | 11.02 | |
Other Non Operating Income (Expenses) | - | - | - | 0.27 | 0.1 | - | |
EBT Excluding Unusual Items | -518.67 | -373.63 | -295.35 | -241.85 | -202.24 | -83.95 | |
Pretax Income | -518.67 | -373.63 | -295.35 | -241.85 | -202.24 | -83.95 | |
Net Income | -518.67 | -373.63 | -295.35 | -241.85 | -202.24 | -83.95 | |
Net Income to Common | -518.67 | -373.63 | -295.35 | -241.85 | -202.24 | -83.95 | |
Shares Outstanding (Basic) | 21 | 19 | 17 | 17 | 15 | 15 | |
Shares Outstanding (Diluted) | 21 | 19 | 17 | 17 | 15 | 15 | |
Shares Change (YoY) | 14.83% | 9.05% | 3.64% | 7.05% | 0.34% | 4.04% | |
EPS (Basic) | -25.02 | -19.99 | -17.23 | -14.63 | -13.09 | -5.45 | |
EPS (Diluted) | -25.02 | -19.99 | -17.23 | -14.63 | -13.09 | -5.45 | |
Free Cash Flow | -433.32 | -325.71 | -225.07 | -184.13 | -157.9 | -41.8 | |
Free Cash Flow Per Share | -20.90 | -17.43 | -13.13 | -11.14 | -10.22 | -2.71 | |
EBITDA | -547.18 | -379.97 | -293.1 | -242.08 | -206.2 | -94.86 | |
D&A For EBITDA | 0.88 | 0.53 | 0.47 | 0.41 | 0.47 | 0.11 | |
EBIT | -548.06 | -380.5 | -293.57 | -242.48 | -206.67 | -94.97 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.